CClinicalTrials.gg
Not yet recruitingNCT07578259SURA'AUpdated Jun 4, 2026

SURA'A Campaign for Stroke Awareness in Primary Health Care Centers

An interventional study of SURA'A Consultation-Based Campaign in Stroke, sponsored by University of Baghdad. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by University of Baghdad · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the effectiveness of a one-week multifaceted Stroke Urgency Recognition, and Action Awareness (SURA'A) consultation-based campaign in increasing stroke awareness and the intention to seek emergency medical help among adults. The research will be conducted at primary health care centers to determine if this specific educational approach can improve the community's response to stroke symptoms.

Read the detailed description

The study will employ a multifaceted campaign based on the SURA'A consultation framework over a period of one week. Participants from primary health care centers will be involved to assess their baseline knowledge and intention regarding stroke. Following the intervention, changes in their awareness levels and help-seeking intentions will be measured and analyzed. This research is approved by the Research Ethical Approval Committee at the University of Baghdad, College of Nursing.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke Awareness
  • Intention to Seek Help
  • Primary Health Care Centers
  • Health Campaign
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 350 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Baghdad is the lead sponsor of 164 studies on the registry; 66 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Participants will be eligible if they:

  1. Age

    • Adults aged ≥18 years residing in Diwaniyah.
  2. Residence o Living in Diwaniyah communities for at least 6 academic months prior to the study.
  3. Access to Primary Health Centers (PHCs)

    • Attending in selected primary health centers where the SURA'A campaign will be implemented.
  4. Cognitive ability

    o Able to understand and answer the survey questions in Arabic.

  5. Consent o Willing to provide informed consent to participate in pre- and post- awareness intervention assessments.

Availability for follow-up

o Agree to participate in both baseline (pre-campaign) and follow-up (post-campaign) assessments.

Exclusion criteria

Exclusion Criteria

Participants will be excluded if they:

  1. Have a previous confirmed diagnosis of stroke (to avoid bias in baseline awareness).
  2. Severe cognitive impairment

    • Have diagnosed dementia, severe mental illness, or cognitive impairment that prevents reliable responses.
  3. Communication barriers

    o Cannot communicate in Arabic or has severe hearing/speech impairment that prevents participation.

  4. Health professionals o Physicians, nurses, paramedics, or students of medical and health colleges (to avoid overestimation of awareness).
  5. Temporary visitors

    o Non-residents or individuals visiting Diwaniyah temporarily.

  6. Refusal or withdrawal o Decline to participate or withdraw at any stage of the study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    SURA'A Consultation-Based Campaign Group

    This experimental group will participate in a one-week multifaceted SURA'A consultation-based campaign. The intervention focuses on increasing stroke awareness and the intention to seek medical help among adults in primary health care centers through structured professional consultations and educational materials.

    Behavioral: SURA'A Consultation-Based Campaign

  • No intervention
    Routine Health Education Group

    Participants in this arm will receive the standard routine health education or conventional care regarding stroke awareness typically provided at the Primary Health Care Centers.

Interventions

  • BehavioralSURA'A Consultation-Based Campaign

    The intervention consists of a one-week multifaceted SURA'A consultation-based campaign. This campaign is designed to increase stroke awareness and the intention to seek help among adults attending Primary Health Care Centers. The multifaceted approach likely includes: Targeted Consultations: Providing direct information to participants regarding stroke symptoms and emergency protocols. Educational Outreach: Utilizing the SURA'A framework-which typically focuses on rapid response (Sura'a meaning "speed" in Arabic)-to emphasize the importance of time-sensitive medical intervention. Community Integration: Implementing the campaign within the primary care setting to reach a diverse adult population during their routine health visits.

06

What researchers measure

Primary outcomes

  1. Stroke Action Test (STAT)

    The Stroke Action Test (STAT) is a validated tool used to assess the participants' knowledge of stroke symptoms and their intended behavioral response (intention to seek help) when witnessing a stroke. It consists of multiple scenarios or questions. Scores are calculated based on correct identified actions, with higher scores indicating better knowledge and more appropriate intended response to stroke symptoms.

    Time frame: Baseline (before the campaign) and 1 week later (immediately after the campaign).

  2. action/intention medical help-seeking sub-scale

    This sub-scale is a component of the Stroke Action Test (STAT). It specifically measures the participants' behavioral intentions and their promptness in seeking medical emergency services (e.g., calling an ambulance) when recognizing stroke signs. It presents various scenarios to evaluate whether the participant would take the correct life-saving action.

    Time frame: Baseline (before the campaign) and 1 week later (immediately after the campaign

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07578259
Lead sponsor
University of Baghdad
Responsible party
aya ahmed (Academic Instructor, University of Baghdad) — Principal investigator
First posted
May 11, 2026
Start date
Jun 10, 2026 (estimated)
Primary completion
Jan 20, 2027 (estimated)
Completion
Apr 10, 2027 (estimated)
Last update
Jun 4, 2026

Study contacts

Aya A Ghayadh, Master
Contact
ayah.ahmed2106m@conursing.uobaghdad.edu.iq
+9647822204528
Sadeq A AL-Fayyadh
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion